Hepatitis E News and Research

RSS

Hepatitis E is a viral hepatitis (liver inflammation) caused by infection with a virus called hepatitis E virus (HEV).

Nerve growth factor positively related with liver cancer - potential therapy target

Nerve growth factor (NGF), as the name says, is an essential peptide factor for the growth and differentiation of neuronal cells.

20 Sep 2007

Rapid test to screen blood approved by the FDA

The U.S. Food and Drug Administration (FDA) has given it's approval for the first rapid test to detect bacterial contamination in blood platelets prior to transfusion.

20 Sep 2007

Possible hepatitis C vaccine

The British Midlands Development Corporation has announced that the University of Nottingham in the British Midlands has released a statement promoting the development of a possible Hepatitis C Vaccine.

18 Sep 2007

Liver cancer marker could yield blood test for early detection

In the face of an emerging liver cancer crisis in Asia, researchers at the Chinese University of Hong Kong have developed a test that could help millions.

18 Sep 2007

FDA clears for marketing rapid test to screen for bacterial contamination in blood platelets

The U.S. Food and Drug Administration has cleared for marketing the first rapid test to detect bacterial contamination in blood platelets prior to transfusion.

18 Sep 2007

Chronic infection persists by targeting stromal cell network in lymphoid organs

One of the biggest challenges to treating infectious diseases and developing preventive vaccines is the ability of many chronic infections to suppress the immune T-cell response over time.

18 Sep 2007

Nanoparticle that delivers vaccines more effectively

Good news for public health: Bioengineering researchers from the EPFL in Lausanne, Switzerland, have developed and patented a nanoparticle that can deliver vaccines more effectively, with fewer side effects, and at a fraction of the cost of current vaccine technologies.

18 Sep 2007

Organ transplantation for HIV-positive patients

Not long ago, organ transplantation was not considered an option for HIV infected patients.

17 Sep 2007

Virus experts step closer to treatment for hepatitis C

Nine hundred of the world's hepatitis C experts are meeting in Glasgow this week to discuss the latest research into the disease at the 14th International Symposium on Hepatitis C Virus and Related Viruses.

13 Sep 2007

Mathematical models to calculate cyclic recurrences of disease

Since the days of Hippocrates, people have known that certain illnesses come and go with the seasons. More recently, researchers have learned that these cyclic recurrences of disease, known as seasonality, are often related to the weather.

13 Sep 2007

HIV infection is on the rise among young men who have sex with men in New York City

HIV infection is on the rise among young men who have sex with men (MSM) in New York City, according to preliminary data from the Health Department.

12 Sep 2007

Lasers used to zap viruses out of blood

A father-son research team working from separate laboratory benches across the country has discovered a new use for lasers - zapping viruses out of blood.

5 Sep 2007

Discovery of monoclonal antibodies which may make a successful Hepatitis C vaccine a reality

Hepatitis C Virus (HCV) infects up to 500,000 people in the UK alone, many of the infections going undiagnosed.

4 Sep 2007

Hepatitis E virus in Europe

Hepatitis E virus infections can be fatal in pregnant women, but until recently doctors thought the disease was confined to China, India and developing countries.

4 Sep 2007

Research looks at hepatitis C recovery

More than 3% of world population is infected with hepatitis C virus (HCV). The outcome of HCV infections is either self recovery or chronic hepatitis, and many of the chronic infections will develop into liver cirrhosis or liver cancer.

30 Aug 2007

Case report on a shining significance in living donor transplantation

Touching stories of living donor transplantation are continuously happening in hospitals.

30 Aug 2007

High-risk behaviors among injection drug users in Afghanistan

In a report that is among the first to describe the prevalence of HIV and Hepatitis B and C viruses in Afghanistan, a researcher from the University of California, San Diego (UCSD) School of Medicine voiced concerns that increasing injection drug use and accompanying high-risk behavior could lead to an HIV epidemic in Afghanistan.

29 Aug 2007